welcome letter
Transcription
welcome letter
call for abstracts Details and submission on www.pamm2015.com Deadline: November 15, 2014 welcome letter The 36th PAMM-EORTC Winter Meeting will focus on ground- breaking innovations in experimental and clinical oncology. The PAMM (Pharmacology And Molecular Mechanism) Meeting is organized under the umbrella of European Organization for Treatment of Cancer (EORTC), to provide a unique opportunity for interdisciplinary You are much welcome to submit materials for consideration by the PAMM-2015 Program Committee. Both PAMM and non-PAMM members are allowed to submit abstracts. Ph.D. students and Post-Doc fellows can submit materials for the Young Researcher session. Abstracts should be prepared as following: - An English language abstract must be in the terminology familiar to specialists. -The text should be succinct and substantive.Beside presenter’s full names and affiliations, the abstract must include: Purpose, Methods, Results, Conclusion, and Significance. - Submit a Microsoft Word document no longer than 750 words or one-page in length. -Ifyou would like to include an image(s),be sure to embed the image(s) in the Word document. Please specify whether you want your abstract to be considered for: - Plenary session (oral presentation - 22-23 January, 2015) - Poster session (22-24 January, 2015) - Young Researchers Session (oral presentation - 24 January, 2015) Marseille and international exchange of ideas on implementing knowledge on Local Organising Committee Dr J. Ciccolini, Marseille, France PAMM Scientific Committee Pr G.J. Peters, Amsterdam, The Netherlands optimizing cancer treatment. The conference will feature presentations from internationally recognized leaders in the field of experimental, translational and clinical oncology. Scientists, researchers, and experts in the field of experimental therapeutics will offer new insights and innovative approaches to treat cancer, along with keynote lectures, oral and poster presentations. Looking forward to meeting you all in Marseille in January 2015. Local Organising Committee Dr J. Ciccolini, Marseille, France PAMM Scientific Committee Pr G.J. Peters, Amsterdam, The Netherlands Meeting Schedule Wednesday, January 21 (p.m.): PAMM Investigational Drugs & GPCO-Unicancer Business groups meetings (invitation only), welcome reception Thursday, January 22: Plenary Sessions, Poster Session & Football Match Friday, January 23: Plenary Sessions, Poster Session & Social Event Saturday, January 24 (a.m.): Young Researcher Session Accommodation Hôtel Novotel Marseille Vieux Port 36, boulevard Charles Livon, 13007 Marseille tel: +33 (0)4 96 11 42 11 www.novotel.com New Hotel of Marseille 71 Boulevard Charles Livon, 13007 Marseille tel: +33 (0)4 91 31 53 15 www.new-hotel.com Radisson Blu Hôtel 38-40, Quai de Rive Neuve, 13007 Marseille tel: +33 (0)4 88 44 52 00 www.radissonblu.fr/hotel-marseille Ibis Budget Vieux Port 46 rue Sainte, 13001 Marseille tel: +33 (0)8 92 68 05 82 www.ibis.com Venue Amphithéâtre Marseille Provence Métropole Les Jardins du Pharo, 58, Bd Charles Livon - 13007 Marseille - France tel: +33 (0)4 95 09 59 00 www.marseille-provence.com contact & registration Etienne Jarry 12, Bd Fellen - 13016 Marseille - France tel: +33 (0)4 91 09 70 53 [email protected] www.comnco.com PRELIMINARY PROGRAM 1. MODELING & SIMULATION IN ONCOLOGY 4. OMICS & IMAGING IN ONCOLOGY Developing mathematical support in oncology is a rising trend both at the bench and the bedside. This session will focus on the variety of models that can be used today to better understand cancer biology and to improve anticancer agents efficacy and clinical use, i.e., mechanistic and semi-mechanistic models, PBPK approaches, computational driven regimen, new PK/PD modeling tools, etc... Translational oncology has benefited from recent advances in the field of in vitro and in vivo imaging, plus the rise of -omics (e.g., metabolomics, proteomics, etc..).This technical session will present the latest tools and applications made available in experimental and translational oncology. KEYWORDS: Computational Oncology - Modeling & Simulation - PK/PD Metronomics has been first introduced in paediatric oncology and is now also considered as an attractive option in a variety of settings in adults. Beside the reduction of drug-induced toxicities, novel mechanisms of action (i.e., antiangiogenic or immunostimulating properties) have emerged from the use of low doses of anticancer drugs. This session will cover the achievements, current limits and expectancies of metronomic chemotherapy in cancer. Metronomics - Paediatrics Oncology - Drug Repositionning 3. BIOGUIDED ONCOLOGY Biomarker-based medicine has been now widely integrated in clinical practice in melanoma, colorectal, lung or breast cancers. Still, there is still a discrepancy between the plethora of putative markers constantly published and the number of validated tests actually reaching bedside applications. This session will cover the latest tools made available to screen patients, the latest markers emerging from molecular biology, and the latest clinical applications in pharmacogenetics and pharmacogenomics. KEYWORDS: Precision medicine - Pharmacogenetics - Pharmacogenomics - Biomarker-based medicine st A. Larsen, Paris, FR U. Ledzewicz, Edwardsville, USA HL. Mc Leod, Tampa, USA C. Meille, Basel, CH G. Milano, Nice, FR E. Pasquier, Randwick, AUS GJ. Peters, Amsterdam, NL JF. Seitz, Marseille, FR JC. Soria, Villejuif, FR C. Van Hasselt, Leiden,NL M. Ychou, Montpellier, FR W. Zamboni, Chapel Hill, USA BY PHONE BY FAX BY MAIL REGISTER ONLINE Optimizing drug delivery of anticancer agents is an attractive strategy to optimize the efficacy/toxicity balance. This session will cover the latest advances in the field of medical chemistry applied to nanomedicine in oncology (i.e., conjugated drugs, nanoparticles, smart drugs). KEYWORDS: Title: F PROF Com&Co SARL, 12 Bd Fellen, 13016 Marseille, France +33 (0) 4 91 09 70 53 +33 (0) 4 96 15 33 08 [email protected] www.pamm2015.com F DR F MR F MS LAST NAME ............................................................................................................................................................................ FIRST NAME........................................................................................................................................................................... INSTITUTION / COMPANY................................................................................................................................................. Medicinal chemistry - Nanoparticles - Drug delivery DEPARTMENT ....................................................................................................................................................................... 6. BIOTECHNOLOGIES & IMMUNOTHERAPY Clinical oncology has benefited over the last decade of the rise of novel bioengineered entities.This session will cover the most recent advances beside monoclonal antibodies (i.e., peptibodies, nanobodies and other entities) that are now developed to adress novel targets, including to trigger immune response against cancer. KEYWORDS: Biologics - Immunotherapy - Novel scafolds ADDRESS ................................................................................................................................................................................ POST CODE ..............................CITY .................................................................................................................................... COUNTRY ............................................................................................................................................................................... PHONE .................................................................................................................................................................................... E-MAIL .................................................................................................................................................................... REGISTRATION FEES 7. WHAT’S IN THE PIPE? BEFORE NOV 15 This session will present all the drugs currently in registration trials or recently approved by experts in the field. KEYWORDS: CONFIRMED SPEAKERS (as of October the 1 , 2014) N. André, Marseille, FR F. André, Villejuif, FR F. Barlési, Marseille, FR JP. Benoit, Angers, FR S. Benzekry, Bordeaux, FR J. Bonner, Newcastle, UK H. Calvert, London, UK R. Costello, Marseille, FR P. Couvreur, Paris, FR M. D'Incalzi, Milano, IT A. Di Paolo, Pisa, IT D. Jodrell, Cambridge, UK M. Joerger, St Gallen, CH Metabolomics - Proteomics - Imaging - Experimental Therapeutics 5. NANOTECHNOLOGY & DRUG DELIVERY 2. METRONOMIC CHEMOTHERAPY KEYWORDS: KEYWORDS: REGISTRATION FORM RETURN TO Next generation drugs - Clinical development MAJOR SPONSORS F F F F Non PAMM members PAMM Members Student Social Event 200 € 150 € 50 € 50 € F PAMM Indoor Football match AFTER NOV 15 250 € 200 € 50 € 55 € F Yes F No PAYMENT F By credit card (Visa / Mastercard / no other card) On protected payment Paybox online form, directly on the website www.comnco.com. Please indicate your Name + PAMM 2015 in the part: «Additional details» PARTNER F By check enclosed (make check in euro payable in France to Com&Co) F By bank transfer to Com&Co SARL Bank Banque Chaix 41-43, Bd Peytral – 13006 Marseille, France IBAN FR76 1017 8000 2600 2626 3880 380 BIC CCBPFRPPCHX